Celastrol Protects From Cholestatic Liver Injury Through Modulation of SIRT1-FXR Signaling

Autor: Fei Li, Fang Liu, Qi Zhao, Jia-Peng Hu, Xue-Rong Xiao, Dandan Hu, Tao Jiang, Yan Cheng, Frank J. Gonzalez, Jin-Hui Yang, Ying-Mei Tang, Wei-Min Bao
Rok vydání: 2019
Předmět:
Zdroj: Molecular & Cellular Proteomics. 18:520-533
ISSN: 1535-9476
DOI: 10.1074/mcp.ra118.000817
Popis: Celastrol, derived from the roots of the Tripterygium Wilfordi, shows a striking effect on obesity. In the present study, the role of celastrol in cholestasis was investigated using metabolomics and transcriptomics. Celastrol treatment significantly alleviated cholestatic liver injury in mice induced by α-naphthyl isothiocyanate (ANIT) and thioacetamide (TAA). Celastrol was found to activate sirtuin 1 (SIRT1), increase farnesoid X receptor (FXR) signaling and inhibit nuclear factor-kappa B and P53 signaling. The protective role of celastrol in cholestatic liver injury was diminished in mice on co-administration of SIRT1 inhibitors. Further, the effects of celastrol on cholestatic liver injury were dramatically decreased in Fxr-null mice, suggesting that the SIRT1-FXR signaling pathway mediates the protective effects of celastrol. These observations demonstrated a novel role for celastrol in protecting against cholestatic liver injury through modulation of the SIRT1 and FXR.
Databáze: OpenAIRE